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Abstract
Background: At the time of initial diagnosis, only 15–20 % of patients with pancreatic cancer present with a
resectable disease. Patients with pancreatic cancer face a poor prognosis. Progression-free survival and overall
survival rates are very limited, so it is important to develop concepts to improve the quality of life for their
remaining lives.
Methods/design: The proposed trial is a randomized controlled intervention study. After pancreatic resection, the
intervention group (cohort A, n = 30 patients) will take part in an intensified physiotherapy program consisting of
endurance and muscle force exercises. The control group (cohort B, n = 30 patients) will take part in standard
physiotherapy. Both groups will receive dietary counseling and, if necessary, substitution for endocrine/exocrine
pancreatic insufficiency. Quality of life will be evaluated using the Short Form-8 Health Survey and the European
Organization for Research and Treatment of Cancer QLQ-C30/QLQ-PAN26 questionnaires.
Discussion: The aim of this study is to investigate whether intensive physiotherapy improves the quality of life
of patients after pancreatic resection. If the results for the intervention group are positive, a multicenter study
should be performed with appropriate statistical power. The progressive postresection program includes a
structured follow-up after pancreatic resection. In this study, all patients will undergo abdominal computed
tomography for follow-up 6 and 12 months postoperatively.
Trial registration: German Clinical Trials Register DRKS00006786. Date of registration 1 October 2014.
Keywords: Intensified physiotherapy, Quality of life after pancreatic resection, Pancreatic cancer, SF-36 Health
Survey, SF-8 Health Survey, EORTC QLQ-C30, EORTC QLQ-PAN26, Progressive postresection program, Follow-up
pancreatic cancer, Walking program
Background
In 2010, more than 16,000 people were diagnosed with
pancreatic cancer in Germany, and almost as many died
of this disease. The mean age of diagnosis is 71 years for
men and 75 years for women. The age-standardized inci-
dence and mortality rates are almost constant, but the
absolute number of cases is increasing as a result of the
aging population [1]. At the time of initial diagnosis,
only 15–20 % of patients with pancreatic cancer present
with a resectable disease [2]. Despite the improved
treatment options, the relative 5-year survival rate has
improved only from 2 % in 1975 to 8 % in 2010 [1, 3].
The clinical and scientific interest in the quality of life
(QOL) of patients with cancer has been increasing since
the 1990s [4]. Intensified physical training has been
shown to measurably increase QOL and reduce fatigue
levels of patients with cancer [5, 6]. So far, there are only
a few studies that have dealt with the issue of QOL and
developed concepts to improve the QOL of patients
after pancreatic resection. Yeo et al. found that patients
with pancreatic and periampullary cancer who have
undergone resection benefit from a structured home-
walking program with respect to fatigue, pain, physical
functioning, and mental health. They modified the Every
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Step Counts graduated walking program to suit patients
with pancreatic and periampullary cancer who under-
went resection [5].
We have modified the walking program used by Yeo
et al. with respect to length. Our program is designed to
last 12 months after surgery instead of 3 months. More-
over, we combine the walking program with muscle
force exercises, as we believe that the patients will bene-
fit from a combination of endurance and muscle force
exercises.
Health-related QOL is often assessed using the Short
Form-36 Health Survey (SF-36). In this questionnaire,
eight columns are used to assess QOL: vitality, physical
functioning, bodily pain, general health perceptions,
physical role functioning, emotional role functioning, so-
cial functioning, and psychological well-being [7].
The Short Form-8 Health Survey (SF-8) was developed
as a shorter form of the SF-36. It was used in the
Telephone Health Survey 2003, and it provides results
that are comparable with those of the SF-36, the most
widely used instrument internationally. Every item of the
SF-8 presents one of the above-mentioned eight
columns of the SF-36 questionnaire. The SF-8 question-
naire has two domains: the physical component score
and the mental component score [8].
To specifically assess the QOL of patients with pancre-
atic cancer, the European Organization for Research and
Treatment of Cancer (EORTC) developed and validated
the QLQ-PAN26 questionnaire, which contains the
domains “disease specific symptoms,” “functional status,”
and “psychosocial components.” This is to be used in
conjunction with the QLQ-C30 questionnaire. The
QLQ-C30 questionnaire was also developed by the
EORTC. It was validated to determine the QOL of pa-
tients with cancer [4]. Both sheets are available in vali-
dated German translations.
High-quality physical therapy and a motivating work-
out schedule could be key parameters for increasing the
QOL of patients with pancreatic cancer. Thus, the main
aim of this study is to investigate the effect of a new
workout scheme on QOL and to ascertain the general
feasibility of the planned approach (i.e., patient’s compli-
ance with the workout schedule). In addition, a more
outlined definition of clinically relevant improvement
will be identified as part of this trial. The patient’s
compliance might have an especially strong impact on the
outcome of any later studies. Thus, it is important to ensure
that the chosen schedule does not overstrain the patients
and instead increases their QOL and overall motivation.
Methods/design
The study protocol has been approved by the Commission
for Impact Assessment Research and Ethics, Carl von
Ossietzky University, Oldenburg, Germany (Drs. 59/2014).
Study population
The study population will consist of patients scheduled
for pancreatic resection for resectable pancreatic cancer,
distal bile duct carcinoma, neuroendocrine tumor,
periampullary carcinoma, duodenal carcinoma, and in-
traductal papillary mucinous neoplasm. Further inclu-
sion criteria are age (≥18 years) and surgery and initial
postoperative hospitalization at the Department of
General and Visceral Surgery, Pius-Hospital, Oldenburg,
Germany.
Exclusion criteria are lack of written consent, physical
inability to participate in the intensified physiotherapy
program, illiteracy, inability to communicate in the
German language, physical or mental disability that
precludes participation in the intensified physiotherapy
program, and lack of compliance.
Individual criteria for discontinuation include with-
drawal of the patient’s consent, a new cardiac risk profile
in the form of myocardial infarction or congestive heart
failure, complications after pancreatic resection in the
form of postoperative mechanical ventilation past the
first postoperative week, and physical or mental inability
to participate in the intensified physiotherapy program.
Study objectives
The primary aim of this study is the assessment of QOL
in the intervention group after intensified physiotherapy
12 months postoperatively, using the SF-8 and the
disease-specific EORTC QLQ-C30/QLQ-PAN26 ques-
tionnaires in the validated German translations. The
longitudinal development of QOL will be measured
using the SF-8 and the QLQ-C30/PAN26 questionnaires.
The different domains of the questionnaires will be
evaluated separately.
The secondary aims of this study include assessment
of study dropouts, assessment of physical performance
using the Short Physical Performance Battery and ergo-
metry, and assessment of nutritional status using meta-
bolic blood levels and the seven-site skinfold method. If
possible, influence on 1-year survival rate, effects of po-
tential adjuvant therapy on QOL, and tumor recurrence
rate after 6 and 12 months will be investigated as well.
This depends on the actual number of patients and the
heterogeneity of the two study groups.
Design and trial flow
Figure 1 shows the flowchart of this study.
For participation in this prospective randomized con-
trolled intervention study, informed written consent is
mandatory. Should the study yield positive results, a
multicenter study with appropriate statistical power will
follow.
The recruitment period is 24 months, and 60 patients
are planned to be enrolled in the study. The intervention
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group (cohort A, n = 30 patients) will receive an intensi-
fied physiotherapy, whereas the control group (cohort B,
n = 30 patients) will receive physiotherapy that is the
standard treatment at the Pancreatic Cancer Center,
Pius-Hospital, Oldenburg, Germany.
The follow-up of the patients enrolled in this study
will be 12 months postoperatively. Evaluation of the data
will take up to 6 months.
The standard physiotherapy of the control group
(cohort B) is individualized on the basis of the physical
condition of the patient and is scheduled for 20 minutes
on 5 days per week. It consists of individual therapy with
relaxation and mobilization exercises, walking, and pos-
sibly even climbing stairs. It is limited to the duration of
the hospital stay.
The intensified physiotherapy of the intervention group
(cohort A) will follow the scheme described below:
1. From the first 24 h after extubation: Ten minutes of
activity three times per day with the aid of a bed
bicycle; target of 50–70 % of maximal heart rate
within the first postoperative week.
2. From the second postoperative week: Fifteen minutes
of walking three times per day plus muscle training
using a TheraBand resistance band and 2-kg
dumbbells and modified squats 5 days per week.
3. After discharge: Every Step Counts graduated
walking program plus continuation of muscle
exercises three times per week.
The physiotherapy program will start within the first
24 h after extubation with three rounds of bed cycling,
each round taking 10 minutes. Starting from the second
postoperative week, patients are supposed to walk three
times per day (15 minutes each) and do muscle exercises
on 5 days per week. Upon discharge from the rehabilita-
tion clinic, up until the 12th postoperative month, patients
are instructed to follow the Every Step Counts graduated
walking program with the minor modifications for re-
sected pancreatic and periampullary cancer patients made
by Yeo et al. [5] (Table 1), and they will be asked to con-
tinue their muscle exercises three times per week.
To minimize further rehabilitation therapy as a con-
founding factor, almost all of our patients will receive re-
habilitation therapy in the same clinic. After discharge,
implementation of the enhanced physiotherapy will be
controlled monthly by study nurses via telephone. The
patients will be asked the following questions:
1. Do you perform the intensified physiotherapy
regularly?
2. If not, for what reason?
Preoperatively, all patients will undergo transthoracic
echocardiography (TTE), as well as an ergometric test to
check for a potential cardiac risk profile. In addition, a
body fat measurement will be performed using the seven-
site skinfold method. For this purpose, the thoracic, ab-
dominal, leg, hip, armpit, triceps, and back pleat
Fig. 1 Flowchart for the progressive postresection program. CT computed tomography, QOL quality of life, pPRP progressive postresection program
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measurements are done with a caliper. The fat-free and
fatty tissue weights, as well as the body fat percentage, can
be calculated with this method and are recorded with the
patient’s age and body weight (Table 2).
The scheduled clinical visits take place 2 days pre-
operatively as well as 5 days and 3, 6, and 12 months
postoperatively with the following measurements:
 2 days preoperatively (+ TTE + ergometry + body
fat measurement)
 5 days postoperatively
 3 months postoperatively (+ ergometry + body fat
measurement)
 6 months postoperatively (+ CT of the abdomen +
ergometry + body fat measurement)
 12 months postoperatively (+ CT of the abdomen +
ergometry + body fat measurement)
The following will constitute the content of the clinical
visits:
1. Assessment of QOL: SF-8, EORTC QLQ-C30/
QLQ-PAN26
2. Documentation of medication/adjuvant treatment
(radiotherapy, chemotherapy)
3. Documentation of the tumor markers CEA and
CA 19-9
4. Assessment of mobility: Short Physical Performance
Battery
5. After 6 and 12 months: CT of the abdomen
6. Preoperatively and at 3, 6, and 12 months
postoperatively: ergometry + body fat measurement
7. Metabolism diagnostics
The metabolism diagnostic measurements will include
size, weight, and body mass index (BMI). The laboratory
parameters measured will include albumin, iron, trans-
ferrin, ferritin, vitamin B12, homocysteine, folic acid,
magnesium, zinc, calcium, parathyroid hormone, vitamin
D, hemoglobin, glycated hemoglobin A1c (HbA1c), chol-
esterol, high-density lipoprotein (HDL) cholesterol, low-
density lipoprotein (LDL) cholesterol, and triglycerides.
Postoperatively, the patients will receive dietary coun-
seling during the course of their hospital stay. For
patients with endocrine pancreatic insufficiency, pan-
creatic enzyme substitution and insulin levels are opti-
mized and diabetes education is provided. All patients are
offered psycho-oncological care.
Sample size considerations
The study is designed as a pilot study. Therefore, no
sample size calculation was performed. The sample size
of 60 patients given here is derived from the feasibility
of patient recruitment within 2 years.
Documentation and data handling
Protocol-required information will be documented in
the case report form, and it will be reviewed and signed
by the investigator or by a designated subinvestigator.
Data transfer will be carried out pseudonymously.
Randomization and blinding
Allocation into the two study groups will be completely
randomized using the program Randomizer.at. The
study cannot be blinded, as patients of the intervention
group will receive a different physiotherapy program and
need to have a bed bicycle.
Statistical methods
Data analysis will include intention-to-treat and per-
protocol analyses. The QOL of patients evaluated with
the SF-8 and EORTC QLQ-C3/QLQ-PAN26 question-
naires will be illustrated in histograms. We will evaluate
the QOL using the following schedule: 2 days preopera-
tively and 5 days and 3, 6, and 12 months postopera-
tively. Furthermore, the course of QOL will be evaluated
with a longitudinal regression model.
A multiple linear regression model that includes the
following covariates will be used: type of surgery (distal
Table 1 Graduated walking program
Time point Exercise program
Month 1 after discharge Warm-up: Walk slowly for 5 minutes
Brisk walking: 10 minutes
Cool-down: Walk slowly for 5 minutes
Month 2 after discharge Warm-up: Walk slowly for 5 minutes
Brisk walking: 20 minutes
Cool-down: Walk slowly for 5 minutes
From month 3 after discharge Warm-up: Walk slowly for 5 minutes
Brisk walking: 25–30 minutes
Cool-down: Walk slowly for 5 minutes
From Yeo et al. [5]
Table 2 Evaluation of body fat in adults according to the
World Health Organization criteria
Age in years Low Healthy Increase Obese
Body fat rating female (% fat)
20–39 <21 21–33 33–39 >39
40–59 <23 23–34 34–40 >40
>60 <24 24–36 35–42 >42
Body fat rating male (% fat)
20–39 <8 8–22 20–25 >25
40–59 <11 11–22 22–28 >28
>60 <13 13–25 25–30 >30
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pancreatectomy, pancreaticoduodenectomy, total pan-
createctomy), cancer (yes or no), age, BMI, mobility,
type of physiotherapy (intensified or standard). We will
also perform a covariate analysis.
Ethical issues
The trial will be performed according to the Declaration
of Helsinki. The study protocol was approved by the
Commission for Impact Assessment Research and
Ethics, Carl von Ossietzky University, Oldenburg,
Germany (Drs. 59/2014). Informed consent will be
obtained and validated using both the physician’s and
patient’s signatures. Participation is voluntary, and
patients can quit the trial at any time without disclosure
of their motives for withdrawal and without fear of
subsequently receiving poor medical care. In the case of
withdrawal, relevant data will be deleted if desired by the
patient. Patient names and all other confidential infor-
mation are subject to medical confidentiality under the
German Data Protection Act. Transmission of data will
be done in an encrypted format. Others not involved in
the trial will have no access to original documents.
Discussion
The absolute number of patients with pancreatic cancer
is increasing, and patients with pancreatic cancer gener-
ally have a poor prognosis, so the QOL of patients with
pancreatic cancer is of clinical and scientific interest.
The complexity of the molecular biology underlying
pancreatic cancer makes a breakthrough in the treat-
ment options in the near future highly unlikely. For this
reason, and because the rates of traditional outcome pa-
rameters such as progression-free survival and overall
survival are low, it is very important to develop concepts
to improve the QOL of patients with pancreatic cancer
in their remaining lives [10]. There are indications that
an improved QOL is associated with an improved overall
survival rate [10].
As mentioned above, intensified physical training has
been shown in particular to measurably increase QOL
and reduce the fatigue level of patients with cancer [5, 6].
There are only a few studies that have dealt with the issue
of QOL and developing concepts to improve the QOL of
patients after pancreatic resection. Yeo et al. described a
benefit for patients with resected pancreatic and periam-
pullary cancer from taking part in a home walking pro-
gram based on the Every Step Counts graduated walking
program [5]. They found significant improvements in fa-
tigue levels, physical functioning, and health-related QOL
[5]. We believe that our patients will profit from muscle
force exercises in addition to endurance exercises. For this
reason, we combine a modified version of the Every Step
Counts graduated walking program with muscle force
exercises. Furthermore, we use the general questionnaire
SF-8 as well as the disease-specific questionnaires EORTC
QLQ-C30 and QLQ-PAN26 to evaluate the QOL of our
patients.
The aim of this study is to investigate whether inten-
sive physiotherapy, consisting of a combination of en-
durance and muscle force exercises, improves the QOL
of patients after pancreatic resection for pancreatic can-
cer, distal bile duct carcinoma, neuroendocrine tumor,
periampullary carcinoma, duodenal carcinoma, or intra-
ductal papillary mucinous neoplasm.
Our hypothesis is that, with the exception of tumor re-
currence, QOL should increase more for the interven-
tion group than for the control group, regardless of the
reason for surgery, if the type of physical therapy really
has an impact on QOL. To be considered clinically rele-
vant, this should be visible even in the heterogeneous
study groups employed here.
The main objective criterion is a potential improve-
ment in QOL in the intervention group after intensified
physiotherapy 12 months postoperatively as measured
by the SF-8 and the EORTC QLQ-C30/QLQ-PAN-26
questionnaires. This pilot study should help us to find
an outlined definition of improvement, which may then
be implemented in a larger (multicenter) study with
appropriate statistical power.
Trial status
Enrollment of the first patient is planned for February
2016.
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